trending Market Intelligence /marketintelligence/en/news-insights/trending/5ui35swv4jfvlnfjm_cekw2 content esgSubNav
In This List

Amedisys chief strategy officer steps down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Amedisys chief strategy officer steps down

Stephen Seim is stepping down as chief strategy officer of Amedisys Inc., effective March 5, under a mutual agreement with the company.

Amedisys said Seim's departure will constitute a termination without cause.